• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Severe coagulation disorder with hypofibrinogenemia associated with the use of tigecycline.

作者信息

Pieringer Herwig, Schmekal Bernhard, Biesenbach Georg, Pohanka Erich

出版信息

Ann Hematol. 2010 Oct;89(10):1063-4. doi: 10.1007/s00277-010-0911-7. Epub 2010 Feb 20.

DOI:10.1007/s00277-010-0911-7
PMID:20174923
Abstract
摘要

相似文献

1
Severe coagulation disorder with hypofibrinogenemia associated with the use of tigecycline.与使用替加环素相关的严重凝血障碍伴低纤维蛋白原血症。
Ann Hematol. 2010 Oct;89(10):1063-4. doi: 10.1007/s00277-010-0911-7. Epub 2010 Feb 20.
2
A case report of patient with severe acute cholangitis with tigecycline treatment causing coagulopathy and hypofibrinogenemia.一例重症急性胆管炎患者使用替加环素治疗导致凝血病和低纤维蛋白原血症的病例报告。
Medicine (Baltimore). 2017 Dec;96(49):e9124. doi: 10.1097/MD.0000000000009124.
3
A Lesser Known Side Effect of Tigecycline: Hypofibrinogenemia.替加环素一种鲜为人知的副作用：纤维蛋白原减少症。
Turk J Haematol. 2018 Mar 1;35(1):83-84. doi: 10.4274/tjh.2017.0310. Epub 2017 Dec 7.
4
Hypofibrinogenemia induced by tigecycline: a potentially life-threatening coagulation disorder.替加环素导致的低纤维蛋白原血症：一种潜在危及生命的凝血障碍。
Infect Dis (Lond). 2015;47(10):743-6. doi: 10.3109/23744235.2015.1043942. Epub 2015 May 8.
5
Life-threatening coagulopathy and hypofibrinogenaemia induced by tigecycline in a patient with advanced liver cirrhosis.替加环素在一名晚期肝硬化患者中诱发的危及生命的凝血病和低纤维蛋白原血症。
Eur J Gastroenterol Hepatol. 2014 Jun;26(6):681-4. doi: 10.1097/MEG.0000000000000087.
6
High-dose tigecycline-associated alterations in coagulation parameters in critically ill patients with severe infections.
Int J Antimicrob Agents. 2015 Jan;45(1):90-3. doi: 10.1016/j.ijantimicag.2014.07.014. Epub 2014 Aug 30.
7
Tigecycline-induced acute pancreatitis: case report and literature review.替加环素所致急性胰腺炎：病例报告及文献综述
Int J Antimicrob Agents. 2009 Nov;34(5):486-9. doi: 10.1016/j.ijantimicag.2009.05.004. Epub 2009 Jun 18.
8
S-thanatin enhances the efficacy of tigecycline in an experimental rat model of polymicrobial peritonitis.S-Thanatin 增强替加环素在实验性多微生物性腹膜炎大鼠模型中的疗效。
Peptides. 2010 Jul;31(7):1231-6. doi: 10.1016/j.peptides.2010.03.034. Epub 2010 Apr 8.
9
Tigecycline: a review of a new glycylcycline antibiotic.替加环素：一种新型甘氨酰环素类抗生素的综述
J Dermatolog Treat. 2005;16(4):207-12. doi: 10.1080/09546630510011810.
10
A practice-based observational study identifying factors associated with the use of high-dose tigecycline in the treatment of secondary peritonitis in severely ill patients.一项基于实践的观察性研究，旨在确定与使用高剂量替加环素治疗重症患者继发性腹膜炎相关的因素。
Rev Esp Quimioter. 2015 Feb;28(1):47-53.

引用本文的文献

1
LC-MS-Based Serum Metabolomic Analysis Predicts the Risk of Tigecycline-Induced Coagulopathy in Critically Ill Patients.基于液相色谱-质谱联用的血清代谢组学分析预测重症患者替加环素诱导凝血功能障碍的风险
Drug Des Devel Ther. 2025 Sep 13;19:8237-8250. doi: 10.2147/DDDT.S539874. eCollection 2025.
2
Impact of Tigecycline on Coagulation in Severe Infections and Effect of Vitamin K1 Intervention: A Retrospective Single-Center Analysis.替加环素对严重感染凝血功能的影响及维生素 K1 干预效果的回顾性单中心分析。
Med Sci Monit. 2024 Nov 3;30:e944778. doi: 10.12659/MSM.944778.
3
Machine learning-based prediction model for hypofibrinogenemia after tigecycline therapy.
基于机器学习的替加环素治疗后低纤维蛋白原血症预测模型。
BMC Med Inform Decis Mak. 2024 Oct 4;24(1):284. doi: 10.1186/s12911-024-02694-x.
4
Incidence, characteristics, and risk factors of hypofibrinogenemia induced by generic tigecycline: a retrospective study.普通替加环素所致低纤维蛋白原血症的发病率、特征及危险因素：一项回顾性研究。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Mar;398(3):2717-2727. doi: 10.1007/s00210-024-03419-7. Epub 2024 Sep 10.
5
Clinical efficacy and safety of tigecycline based on therapeutic drug monitoring for carbapenem-resistant Gram-negative bacterium pneumonia in intensive care units.基于治疗药物监测的替加环素治疗重症监护病房耐碳青霉烯类革兰阴性菌肺炎的临床疗效及安全性。
BMC Infect Dis. 2023 Nov 27;23(1):830. doi: 10.1186/s12879-023-08815-7.
6
Safety of Tigecycline in Patients on Antithrombotic Therapy: A Single-Center Retrospective Study.替加环素在抗血栓治疗患者中的安全性：一项单中心回顾性研究。
Pharmacology. 2023;108(6):540-549. doi: 10.1159/000532001. Epub 2023 Sep 26.
7
Development and Validation of a Nomogram for Predicting Tigecycline-Related Coagulopathy: A Retrospective Cohort Study.用于预测替加环素相关凝血病的列线图的开发与验证：一项回顾性队列研究
Infect Drug Resist. 2023 Jan 24;16:423-434. doi: 10.2147/IDR.S388438. eCollection 2023.
8
Eravacycline Associated Hypofibrinogenemia: A Case Series of Transplant Patients With Infections and Review of Literature.依拉环素相关的低纤维蛋白原血症：一组感染移植患者的病例系列及文献综述
Open Forum Infect Dis. 2022 Dec 15;9(12):ofac591. doi: 10.1093/ofid/ofac591. eCollection 2022 Dec.
9
Risk factors of tigecycline-associated fibrinogen reduction in patients with renal transplantation: a case-control study.肾移植患者中替加环素相关纤维蛋白原降低的危险因素：一项病例对照研究。
Transl Androl Urol. 2022 Oct;11(10):1410-1418. doi: 10.21037/tau-22-522.
10
Incidence, characteristics and risk factors of hypofibrinogenemia associated with tigecycline: A multicenter retrospective study in China.替加环素相关低纤维蛋白原血症的发生率、特征及危险因素：一项中国多中心回顾性研究
Front Pharmacol. 2022 Oct 11;13:943674. doi: 10.3389/fphar.2022.943674. eCollection 2022.